Statistics

Total Visits

Views
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer(legacy) 137
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer(legacy) 101

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer 6 4 8 0 8 7 9

File Downloads

Views

Top Country Views

Views
United States 61
China 35
Australia 9
Netherlands 8
France 7
Vietnam 6
Singapore 4
Germany 2
United Kingdom 2
Argentina 1

Top City Views

Views
Beijing 22
Ashburn 20
Rotterdam 8
Kaleen 7
Hanoi 6
Zhengzhou 6
Fairfield 4
Cambridge 3
Boardman 2
Dearborn 2